123 related articles for article (PubMed ID: 32896486)
61. Primary colon lymphomas: An analysis of our experience over the last 18 years.
Hasturk D; Akturk Esen S; Buyukaksoy M; Civelek B; Seven I; Uncu D
Medicine (Baltimore); 2024 May; 103(19):e38013. PubMed ID: 38728507
[TBL] [Abstract][Full Text] [Related]
62. Oncological Outcome of Conversion Surgery After Preoperative Chemotherapy for Metastatic Pancreatic Cancer.
Hank T; Klaiber U; Hinz U; Schütte D; Leonhardt CS; Bergmann F; Hackert T; Jäger D; Büchler MW; Strobel O
Ann Surg; 2023 May; 277(5):e1089-e1098. PubMed ID: 35758505
[TBL] [Abstract][Full Text] [Related]
63. Prognostic Significance of Preoperative and Postoperative Evaluation of Combined Tumor Markers for Patients With Colon Cancer.
Pan HF; Zheng ZF; Zhao ZY; Liu Z; Huang SH; Chi P
Surg Laparosc Endosc Percutan Tech; 2024 May; ():. PubMed ID: 38736427
[TBL] [Abstract][Full Text] [Related]
64. Identification of patients at high risk for recurrence in carcinoma of the ampulla of Vater: Analysis in 460 patients.
Narita M; Hatano E; Kitamura K; Fukumitsu K; Kitagawa H; Hamaguchi Y; Yazawa T; Terajima H; Kitaguchi K; Hata T;
Ann Gastroenterol Surg; 2024 Mar; 8(2):190-201. PubMed ID: 38455488
[TBL] [Abstract][Full Text] [Related]
65. Completion of adjuvant S-1 chemotherapy after surgical resection for biliary tract cancer: A single center experience.
Iwaki K; Yoh T; Nishino H; Nishio T; Koyama Y; Ogiso S; Ishii T; Kanai M; Hatano E
Asian J Surg; 2024 Mar; 47(3):1383-1388. PubMed ID: 38160154
[TBL] [Abstract][Full Text] [Related]
66. Association between adjuvant chemotherapy and survival in stage I gastric cancer patients after curative resection.
Chen Q; Xiao H; Zhang L; You J; Jin Z; Zhang B
Gastroenterol Rep (Oxf); 2023; 11():goad070. PubMed ID: 38058518
[TBL] [Abstract][Full Text] [Related]
67. Assessment of Cancer Center Variation in Textbook Oncologic Outcomes Following Colectomy for Adenocarcinoma.
Sweigert PJ; Eguia E; Baker MS; Link CM; Hyer JM; Paredes AZ; Tsilimigras DI; Husain S; Pawlik TM
J Gastrointest Surg; 2021 Mar; 25(3):775-785. PubMed ID: 32779080
[TBL] [Abstract][Full Text] [Related]
68. Surveillance for asymptomatic recurrence in resected stage III colon cancer: does it result in a more favorable outcome?
Smoragiewicz M; Lim H; Peixoto RD
J Gastrointest Oncol; 2015 Jun; 6(3):268-73. PubMed ID: 26029453
[TBL] [Abstract][Full Text] [Related]
69. Prognostic Subgroups among Patients with Stage II Colon Cancer.
Boland CR; Goel A
N Engl J Med; 2016 Jan; 374(3):277-8. PubMed ID: 26789877
[TBL] [Abstract][Full Text] [Related]
70. Small bowel adenocarcinomas with favorable prognoses by radical resection and adjuvant chemotherapy: a case series of five cases.
Nishioka Y; Matsumoto Y; Imanishi S; Endo S; Toyozumi T; Kurata Y; Sasaki T; Ohira G; Hayano K; Matsubara H
Surg Case Rep; 2023 Oct; 9(1):188. PubMed ID: 37899355
[TBL] [Abstract][Full Text] [Related]
71. Standardizing data collection in adjuvant colon cancer trials: A consensus project from the IDEA and ACCENT international consortia and national experts.
Taieb J; Basile D; Seligmann J; Argiles G; André T; Gallois C; Goldberg RM; Yothers G; Sobrero A; Meyerhardt JA; Souglakos J; Labianca R; Iveson T; Church DN; Arnold D; Tie J; Gill S; Laurent-Puig P; Yoshino T; Lonardi S; Shi Q
Eur J Cancer; 2024 Jul; 206():114118. PubMed ID: 38810317
[TBL] [Abstract][Full Text] [Related]
72. Is a less-intensive follow-up for colon cancer in early stages reasonable?
Esswein K; Volpi M; Ninkovic M; Kröpfl V; Gasser E; Lorenz A; Stecher L; Kafka-Ritsch R; Schneeberger S; Öfner D; Perathoner A
Int J Colorectal Dis; 2023 Mar; 38(1):60. PubMed ID: 36869966
[TBL] [Abstract][Full Text] [Related]
73. Physical activity in recurrent colon cancer: Cancer and Leukemia Group B/SWOG 80702 (Alliance).
Brown JC; Ma C; Shi Q; Zemla T; Couture F; Kuebler P; Kumar P; Tan B; Krishnamurthi S; Chang V; Goldberg RM; Venook AP; Blanke CD; O'Reilly EM; Shields AF; Meyerhardt JA
Cancer; 2023 Dec; 129(23):3724-3734. PubMed ID: 37651160
[TBL] [Abstract][Full Text] [Related]
74. Association between physical activity and the time course of cancer recurrence in stage III colon cancer.
Brown JC; Ma C; Shi Q; Niedzwiecki D; Zemla T; Couture F; Kuebler P; Kumar P; Hopkins JO; Tan B; Krishnamurthi S; O'Reilly EM; Shields AF; Meyerhardt JA
Br J Sports Med; 2023 Aug; 57(15):965-971. PubMed ID: 36878665
[TBL] [Abstract][Full Text] [Related]
75. Assessment of Attitudes Toward Initiation of Immediate Adjuvant Chemotherapy for Colon Cancer.
Mesiti AM; Brouwer J; Jafari MD; Qiu Y; Wenzel L; Carmichael J; McKinney C; Zell JA; Pigazzi A
J Surg Res; 2023 Mar; 283():658-665. PubMed ID: 36455419
[TBL] [Abstract][Full Text] [Related]
76. Combination therapy in high-risk stage II or stage III colon cancer: current practice and future prospects.
Bastos DA; Ribeiro SC; de Freitas D; Hoff PM
Ther Adv Med Oncol; 2010 Jul; 2(4):261-72. PubMed ID: 21789139
[TBL] [Abstract][Full Text] [Related]
77. Persistent inequalities in 90-day colon cancer mortality: an English cohort study.
Fowler H; Belot A; Njagi EN; Luque-Fernandez MA; Maringe C; Quaresma M; Kajiwara M; Rachet B
Br J Cancer; 2017 Oct; 117(9):1396-1404. PubMed ID: 28859056
[TBL] [Abstract][Full Text] [Related]
78. Predicting Chemotherapy Toxicity and Death in Older Adults with Colon Cancer: Results of MOST Study.
Retornaz F; Guillem O; Rousseau F; Morvan F; Rinaldi Y; Nahon S; Castagna C; Boulahssass R; Grino M; Gholam D
Oncologist; 2020 Jan; 25(1):e85-e93. PubMed ID: 31387952
[TBL] [Abstract][Full Text] [Related]
79. Multivariate Analysis of the Survival Rate for Treatment Modalities in Incurable Stage IV Colorectal Cancer.
Kim SK; Lee CH; Lee MR; Kim JH
J Korean Soc Coloproctol; 2012 Feb; 28(1):35-41. PubMed ID: 22413080
[TBL] [Abstract][Full Text] [Related]
80. Immunotherapy utilization in stage IIIA melanoma: less may be more.
Frey AE; Kerekes DM; Khan SA; Tran TT; Kluger HM; Clune JE; Ariyan S; Sznol M; Ishizuka JJ; Olino KL
Front Oncol; 2024; 14():1336441. PubMed ID: 38380358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
